News

SPARK-BIH, MDC and Bayer hosted the first joint Berlin Science Slam to strengthened local collaboration with short presentations and the exchange of young scientists.

SPARK-BIH and DHA presented their health innovation programs during the Danish state visit at the Charité

The Cluster of Excellence NeuroCure of the Charité – Universitätsmedizin Berlin provides a new program, tailored to the needs of early career researchers, who are interested to explore problem-solving tools beyond science and potentially translate their ideas into ‘the real world’.

In October 2021, Dr. Tanja Rosenmund, head of SPARK-BIH, together with her team welcomed 10 new projects to the SPARK-BIH program. She and her team are excited to support the new SPARKees to translate their innovation from bench to bedside.

SPARK Europe is excited to announce the first SPARK Europe featured podcast series. Dr. Felix Lorenz, SPARKee and founder of the Berlin-based Captain T-Cell start-up project, explains what technology lies behind Captain T-Cell, how it can help transform cancer therapy for patients, and why he wanted to start a company.

The German Federal Ministry of Education and Research was so impressed by the research proposal from SPARKee Prof. Simone Spuler that it made €3.3 million available to the team to carry out a clinical trial. Prof. Spuler and her team are using muscle stem cells to build new muscle. The first patient will be treated in a few months' time.

To mark the occasion of Rare Disease Day 2021 on February 28, the Berlin Institute of Health spoke to SPARKee Prof. Peter Kühnen in the BIH podcast about hereditary obesity. Prof. Peter Kühnen studied in a clinical trial a new drug targeting a promising target for treatment of hereditary obesity. The SPARK-BIH program funded the respective project of Prof. Peter Kühnen and Prof. Heike Biebermann.

Dr. Panagiotis Fikatas, Senior Surgeon at Charité - Universitätsmedizin Berlin, invented a surgical device using a knot technology for minimally invasive surgery. Early prototyping and development work was significantly supported by the SPARK-BIH program with the Validation Fund and funds from the Stiftung Charité.